BioSpace News Archive

Respiratory Motion Inc. (RMI) today announced the appointment of Chas Taylor and Bob Smouse, MD, FACR to the Board of Directors, Chas Taylor has been named Chairman of the Board,

Liquid Wire Inc. announced that it has successfully closed a $10 million Series A financing round to expand its stretchable electronics technologies into the medical wearables market.

Today, Sensory Cloud, a technology startup that designs solutions to problems of human well-being and healthcare through pioneering discoveries at the frontiers of olfaction and respiratory biology, announced the publication of a new peer-reviewed paper in QRB Discovery,

The unprecedented emergency authorization of remdesivir for treating COVID-19 only four months after the virus was discovered was enabled by decades of basic research on the drug’s biological target and drugs with similar parent structures, and was supported by $6.5 billion in NIH funding, according to a study from Bentley University

Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), announced today that the Department of Defense (DOD), through the Joint Science and Technology Office of the Defense Threat Reduction Agency (DTRA), has awarded the company with three biomanufacturing contracts with a combined value of more than $16 million.

Pac Roots Cannabis Corp. (“PacRoots” or the “Company”) (CSE:PACR), is pleased to announce the execution of a definitive Investment Agreement with Rock Creek Farms (“RCF”) on a 100 acre commercial hemp operation, in Rock Creek, British Columbia.

Frontage Holdings Corporation ( “Frontage” or the “Group”, 1521.HK), a contract research organization (“CRO”) providing integrated, science-driven research and development services with presence in both North America and China, today announced Frontage Laboratories, Inc. (“Frontage Labs”), a wholly-owned subsidiary of the Group, purchased ACME Bioscience Inc. (“ACME”)

As evidence showing a real risk of airborne transmission of SARS-CoV-2 (Coronavirus responsible for COVID-19) continues to mount, Integrated Viral Protection (IVP) announced today the publication of a peer-reviewed paper detailing a novel biodefense indoor air protection technology.

CAGE Bio Inc. announced a research and development agreement with Nitto Denko Corporation for a transdermal formulation of undisclosed molecules.

Soterix Medical Inc. announces it has received FDA Investigational Device Exception (IDE) to launch a trial of transcranial Direct Current Stimulation-Limited Total Energy (tDCS-LTE) neuromodulation at-home for patients with Major Depressive Disorder (MDD)